NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Year-over-year book value per share growth
Latest
-27.79%
↑ 44% vs avg
Percentile
P33
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
-49.54%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -27.79% |
| Q3 2025 | 4.69% |
| Q2 2025 | 364.92% |
| Q1 2025 | -61.98% |
| Q4 2024 | 209.90% |
| Q3 2024 | -72.10% |
| Q2 2024 | -25.98% |
| Q1 2024 | -19.21% |
| Q4 2023 | -30.71% |
| Q3 2023 | 19.12% |
| Q2 2023 | -33.82% |
| Q1 2023 | -33.05% |
| Q4 2022 | -14.99% |
| Q3 2022 | -9.68% |
| Q2 2022 | -19.10% |
| Q1 2022 | -21.69% |
| Q4 2021 | 89.66% |
| Q3 2021 | -26.30% |
| Q2 2021 | -23.38% |
| Q1 2021 | 427.29% |
| Q4 2020 | -36.75% |
| Q3 2020 | 139.45% |
| Q2 2020 | 34.34% |
| Q1 2020 | -10.42% |
| Q4 2019 | -268.54% |
| Q3 2019 | -342.53% |
| Q2 2019 | -151.09% |
| Q1 2019 | 107.98% |
| Q4 2018 | -33.80% |
| Q3 2018 | 58.51% |
| Q2 2018 | -12.51% |
| Q1 2018 | -25.74% |
| Q4 2017 | -38.17% |
| Q3 2017 | -2037.61% |
| Q2 2017 | -8.90% |
| Q1 2017 | -211.46% |
| Q4 2016 | 186.94% |
| Q3 2016 | -5.74% |
| Q2 2016 | -17.44% |
| Q1 2016 | -4.00% |